Recruiting
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
NCT06628947
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
- Locations
-
- Save Sight Institute Sydney, New South Wales, Australia
- Queensland Eye Institute Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Cerulea Clinical Trials East Melbourne, Victoria, Australia